SCHEDULE: Kingdon Capital Exits SCYNEXIS Stake, Ownership Now 0%

Sentiment:

Beneficial Ownership Amendment 17 February 2026 10:12 AM

Kingdon Capital Management and Mark Kingdon have reported a complete divestment of their beneficial ownership in SCYNEXIS INC, reducing their stake to 0%.

Worse than expectedThe complete divestment of shares by Kingdon Capital Management and Mark Kingdon, reducing their beneficial ownership to 0%, is generally perceived as a negative signal for the company's stock.

Summary

Kingdon Capital Management, L.L.C. and Mark Kingdon have filed an Amendment No. 3 to Schedule 13G.
The filing indicates that as of December 31, 2025, both Kingdon Capital Management, L.L.C. and Mark Kingdon beneficially own 0 shares of SCYNEXIS INC Common Stock.
This represents 0% of the class of securities for both reporting persons.
The reporting persons certify that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development, as a complete exit by an institutional investor typically reflects a bearish outlook or a reallocation of capital away from the company.

Negatives

Kingdon Capital Management, L.L.C. and Mark Kingdon have completely divested their beneficial ownership in SCYNEXIS INC, reducing their stake to 0%.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding SCYNEXIS INC's business or financial performance.

Industry Context

StockSavvy.ai notes that a complete divestment by an institutional investor like Kingdon Capital Management can signal a loss of confidence in the company's future prospects or a strategic shift in the investor's portfolio allocation. This move could potentially influence other institutional investors and retail shareholders, leading to increased scrutiny of SCYNEXIS INC's fundamentals and market position within the biotechnology or pharmaceutical sector.

Stakeholder Impact

Shareholders: The complete divestment by an institutional investor may lead to negative sentiment and potential downward pressure on SCYNEXIS INC's stock price, impacting shareholder value.

Key Dates

Date	Description
12/31/2025	Date of event which required the filing of this statement, indicating the beneficial ownership change.
02/17/2026	Date of the Joint Filing Agreement and signature date for the Schedule 13G Amendment No. 3.

Recommendation

sell

The complete divestment by a significant institutional investor like Kingdon Capital Management, reducing their stake to 0%, signals a strong lack of confidence in SCYNEXIS INC's future performance. This action by a sophisticated investor suggests that the stock may face headwinds, making a 'sell' recommendation prudent for investors considering their position.

Keywords

SCYNEXIS INC, Kingdon Capital Management, Mark Kingdon, Schedule 13G/A, Beneficial Ownership, Institutional Investor, Divestment, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.